NDC 17856-1122-6 - MAX relief junior Grape
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1122
- Requested NDC
- 17856-1122-6
- Package NDCs from labels
- 17856-1122-5, 17856-1122-1, 17856-1122-8, 17856-1122-4, 17856-1122-6, 17856-1122-2, 17856-1122-7, 17856-1122-3, 17856-1122-9
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MAX relief junior Grape - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2026-02-13 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1122-1 | MAX relief junior Grape | 50 in 1 BOX, UNIT-DOSE | LIQUID | 50 | 4 | |
| 17856-1122-2 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-3 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-4 | MAX relief junior Grape | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 4 | |
| 17856-1122-5 | MAX relief junior Grape | 20.3 mL in 1 CUP, UNIT-DOSE | LIQUID | 20.3 | 4 | |
| 17856-1122-6 | MAX relief junior Grape | 1.25 mL in 1 SYRINGE | LIQUID | 1.25 | 4 | |
| 17856-1122-7 | MAX relief junior Grape | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 4 | |
| 17856-1122-8 | MAX relief junior Grape | 15 mL in 1 CUP, UNIT-DOSE | LIQUID | 15 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 60 in 1 BOX, UNIT-DOSE | LIQUID | 60 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 1 mL in 1 SYRINGE | LIQUID | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1122 | MAX RELIEF JUNIOR GRAPE (CHILDRENS ACETAMINOPHEN) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, 10 package rows | 20250514_562d7901-44d6-4d9b-be8b-a8d468a22c43.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1122-1 | ML - Milliliter | 17856-1122 | 6ff0a9b2-03be-4ea1-8611-39fbd5be4f4b | 1 | 2026-02-05 |
| 17856-1122-5 | ML - Milliliter | 17856-1122 | 8df3891c-73a2-47c4-bcee-72eea1317e38 | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daytime Cold and Flu Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Shield Pharmaceuticals Corp | 67849e09-2056-4013-98b1-d003ed3250a2 | 2026-08-31 | Warnings | 362O9ITL9D |
| MAX relief junior | ACETAMINOPHEN | Akron Pharma Inc. | 0e43b885-3843-4f11-9a53-02a38c228313 | 2026-08-31 | Warnings | M013 307668 362O9ITL9D |
| MAX relief junior | CHILDREN ACETAMINOPHEN | Akron Pharma Inc. | d7874e4d-0b38-4bb1-9a62-aa4f66d9baf9 | 2026-08-31 | Warnings | M013 307668 362O9ITL9D |
| MAX relief junior Grape | CHILDREN ACETAMINOPHEN | Akron Pharma Inc. | 3c7a7f40-4963-4fd1-942e-93fa08a45830 | 2026-08-31 | Warnings | M013 307668 362O9ITL9D |
| Genexa Kids Pain and Fever | ACETAMINOPHEN | Genexa Inc. | 5a615118-33c9-1520-e063-6394a90a21a6 | 2026-08-31 | Warnings | M013 307668 362O9ITL9D |
| CareOne DayTime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | American Sales Company | c4732df0-e760-4283-98f3-2d08c8cd6a9e | 2026-08-31 | Warnings | 362O9ITL9D |
| Acetaminophen PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | United Natural Foods, Inc. dba UNFI | 24173e77-92ec-4a87-a471-d6867837c180 | 2026-08-31 | Warnings | 362O9ITL9D |
| acetaminophen extra strength | ACETAMINOPHEN | Sam's West Inc | dd99efd0-4ca4-4dc6-a940-bebd17ac8f8d | 2026-08-28 | Warnings | M013 362O9ITL9D |
| Medline | ACETAMINOPHEN | Medline Industries, LP | 4b0cc37c-56ce-6a73-e063-6394a90a80a3 | 2026-08-28 | Warnings | M013 362O9ITL9D |
| Medline | ACETAMINOPHEN | Medline Industries, LP | 52f7367f-6ed0-700e-e063-6294a90a3eaa | 2026-08-28 | Warnings | 362O9ITL9D |
| Medline | ACETAMINOPHEN | Medline Industries, LP | 4b1bdd14-8d2c-e750-e063-6394a90ad645 | 2026-08-28 | Warnings | M013 362O9ITL9D |
| Aspirin 81 mg | ASPIRIN | HAWAII REPACK, INC. | ac94cce3-9a39-41de-bb8b-10a5e5b8e83b | 2026-08-28 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | REMEDYREPACK INC. | 464e404a-1957-44a2-a53a-f2a9d3c15bde | 2026-08-28 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Aspirin | ASPIRIN | WinCo Foods, LLC | a0a19cd1-eb8a-4773-be00-78de90d2a3c3 | 2026-08-28 | Warnings | M013 |
| Pain Reliever PM Extra strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Walgreens | 54cbbc5f-908b-47b2-b37f-3646354d3568 | 2026-08-27 | Warnings | 362O9ITL9D |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | REMEDYREPACK INC. | 40d4a71e-341e-48b3-b925-ba35b7910dff | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| major acetaminophen | ACETAMINOPHEN | Major Pharmaceuticals | ca9e1dae-eefb-4653-952f-2fde09059693 | 2026-08-27 | Warnings | 362O9ITL9D |
| daytime cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | Amazon.com Services LLC | 6de619d3-0ab0-43e7-8dac-7bbd5368ac65 | 2026-08-27 | Warnings | 362O9ITL9D |
| Nighttime Cold and Flu Maximum Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCI, PHENYLEPHRINE HCI | Walgreens | 37896933-3ed3-457f-8a32-ee0d784a19e8 | 2026-08-27 | Warnings | 362O9ITL9D |
| equaline dual action pain reliever | ACETAMINOPHEN, IBUPROFEN | United Natural Foods, Inc. dba UNFI | ae0dc3f1-ee6f-4347-af5d-70f45dd68bdb | 2026-08-27 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.